Provided by Tiger Trade Technology Pte. Ltd.

Healthcare Realty Trust Inc

18.26
-0.1400-0.76%
Volume:7.77M
Turnover:141.42M
Market Cap:6.26B
PE:-70.16
High:18.31
Open:18.27
Low:18.13
Close:18.40
52wk High:22.04
52wk Low:16.31
Shares:342.72M
Float Shares:340.47M
Volume Ratio:2.12
T/O Rate:2.28%
Dividend:0.96
Dividend Rate:5.26%
EPS(TTM):-0.2603
EPS(LYR):-0.7100
ROE:-1.92%
ROA:0.86%
PB:1.48
PE(LYR):-25.72

Loading ...

GUIDANCE: (HR) Healthcare Realty Trust Expects 2026 Normalized FFO Range $1.62-$1.66, vs. FactSet Est of $1.62

MT Newswires Live
·
Jul 31

Healthcare Realty Trust Q2 Net Loss Narrows, Lifts 2026 Outlook

Reuters
·
Jul 31

Healthcare Realty Trust Outlook FY Normalized Ffo Per Share $1.62 - $1.66

THOMSON REUTERS
·
Jul 31

Healthcare Realty 2Q FY26 GAAP Net Loss Narrows to $43.5 Million; Revenue Falls 5.3% to $281.8 Million

Reuters
·
Jul 31

Healthcare Realty Trust Q2 Adjusted FFO Per Share USD 0.41

Reuters
·
Jul 31

Healthcare Realty Trust Q2 Ffo USD 126.142 Million

THOMSON REUTERS
·
Jul 31

Newly FDA-Approved REVTORPYK™ (gedatolisib) Included in the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines for HR+/HER2- Locally Advanced or Metastatic Breast Cancer

GlobeNewswire
·
Jul 30

ADP Stock And 2 HR Software Picks For Rising Compliance Demand

Simply Wall St.
·
Jul 30

Healthcare Realty Trust Inc Expected to Post a Loss of 1 Cent a Share - Earnings Preview

Reuters
·
Jul 29

Mare Nostrum Returns to Growth as Refocused HR Model Shows Resilience

TIPRANKS
·
Jul 28

AI-Focused Upgrades And New HR Chief Might Change The Case For Investing In F5 (FFIV)

Simply Wall St.
·
Jul 28

Faron posts encouraging survival signal in bexmarilimab HR-MDS trial

TIPRANKS
·
Jul 27

Earning Preview: Healthcare Realty Trust Inc revenue expected to decrease by 6.33%, institutions lean cautious on near-term growth

Earnings Agent
·
Jul 24

Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01

GlobeNewswire
·
Jul 20

Petco Announces Planned Transition in HR Leadership

TIPRANKS
·
Jul 18

Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer

GlobeNewswire
·
Jul 15

InnoCare Announces Publication in STTT (IF=81.2) of Phase 3 Results Showing Orelabrutinib Significantly Prolonged Progression-Free Survival in Treatment-Naïve CLL/SLL

GlobeNewswire
·
Jul 14

Leifras forms strategic alliance with HR Produce

TIPRANKS
·
Jul 13

Analysts Conflicted on These Real Estate Names: Four Corners Property (FCPT) and Healthcare Realty Trust (HR)

TIPRANKS
·
Jul 09

Capri Global Strengthens Senior Bench With New HR and Collections Chiefs

TIPRANKS
·
Jul 08